Abhishek Karande of SBI Capital Securities is of the view that one may buy Divis Laboratories on correction as the stock may touch Rs 1400.
first published: Jan 14, 2014 03:20 pm
A collection of the most-viewed Moneycontrol videos.

Live: Will Nifty extend gains to third day and reclaim record highs? | Opening Bell

Decoding Small-Caps - Opportunities, Risks, and the Right Way to Invest

Live: Broad-based buying lifts D-Street for 2nd day, Nifty above 26,100 | Closing Bell

In your 20s? Quick hacks to turn your money mess into money moves
You are already a Moneycontrol Pro user.

